AI-Driven, Faster, Smarter Clinical Trials

Optimize trial design, uncover biomarkers, and make data-driven decisions with confidence. PhaseV’s AI/ML-powered platform enhances trial efficiency, reduces costs, and accelerates patient outcomes.

Millions of clinical Trial simulations conducted in minutes
Backed by real-world case studies and scientific publications.
Empowering 30+ biopharma and CROs globally.
AI-Driven Solutions for Smarter, More Successful Trials

PhaseV Platform: Powering the Future of Clinical Development

AI and machine learning optimize every stage of clinical development—accelerating timelines, reducing costs, and improving patient outcomes with data-driven confidence.

Optimize Trial Design with AI-Powered Simulations

Run millions of simulations in minutes to refine clinical trial designs, improve efficiency, and maximize success rates.

  • Accelerate trial timelines with optimized Bayesian, adaptive, and fixed trials
  • Reduce patient burden and optimize sample sizes
  • Make real-time adjustments with data-driven decision-making
  • Designed for multi-stakeholder use be it clin ops, clinical development, biostats, or other stakeholders
See How It Works
Reduce trial risk and optimize outcomes

Identify the Right Patients for the Right Treatment

Leverage AI to uncover treatment response patterns and identify high-potential patient subgroups for precision medicine.

  • Detect heterogeneity even in complex biological data
  • Improve patient stratification and trial efficiency
  • Minimize false discoveries with rigorous AI validation
See How It Works
Reduce trial risk and optimize outcomes

Uncover Biomarker Insights & Guide Treatment Strategy

Build AI-powered causal models to analyze biomarker correlations and drive smarter treatment decisions.

  • Identify key biological drivers of disease progression
  • Enhance indication selection with predictive insights
  • Optimize treatment planning with real-world data models
See How It Works
Reduce trial risk and optimize outcomes

Optimizing Trials Through Causal Machine Learning

PhaseV enhances clinical operations by applying causal machine learning across the trial lifecycle, from site selection to real-time monitoring.

  • Identify sites aligned with the drug’s mechanism of action
  • Maximize diversity and anticipate patient heterogeneity impacts.
  • Track enrollment, progression, and dropouts with virtual control arms.
See How It Works
Reduce trial risk and optimize outcomes

Take the Next Step Toward Smarter Clinical Trials

Additional Solutions for Smarter Clinical Development

Optimize trials, reduce costs, and accelerate drug development.

PhaseV Data
Lake

Leverage 300,000+ patient-level data across multiple therapeutic areas for deeper insights.

Causal ML for Site
Selection

Predict recruitment success and optimize trial site selection to reduce delays and costs.

Indication Selection & Expansion

Identify new indications and use cases for assets to guide life cycle management decisions.

Clinical Asset
Evaluation

Uncover hidden value in clinical assets and determine the probability of success to guide investment decisions.

Medical
Coder

Leverage 300,000+ patient-level data across multiple therapeutic areas for deeper insights.

Transform Your Clinical Trials
Insights

Real Results: Transforming Clinical Trials